Business (Details Narrative) - USD ($)		3 Months Ended				6 Months Ended		12 Months Ended
	May 18, 2023	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	May 11, 2023	Dec. 31, 2021
Ordinary shares									25,000,000
Net Income (Loss) Attributable to Parent		$ 681,030	$ 430,063	$ 480,288	$ 860,163	$ 1,111,093	$ 1,340,451
Net loss attributable to common stockholders		691,791		832,026		1,121,854	1,692,189	$ 3,972,993
Net Cash Provided by (Used in) Operating Activities						157,767	85,122	143,905
Equity, Attributable to Parent		12,142,352	$ 12,310,383	$ 11,131,459	$ 10,867,921	12,142,352	$ 11,131,459	$ 11,880,320		$ 10,007,758
Long-Term Debt, Gross		$ 1,289,854				$ 1,289,854
Cantheon Capital [Member]
Intended investment	$ 3,125,000
Clinical trail costs percentage	25.00%